Peter Thiel and Robert Davis are not publicly documented as business partners, colleagues, relatives, or direct investment associates. The most plausible source of confusion is a real relationship between Thiel-founded Palantir Technologies and Merck KGaA of Germany, which is a completely separate company from Merck & Co., Inc., the U.S. pharmaceutical company led by Robert M. “Rob” Davis.
That distinction matters. Articles and search results sometimes shorten both companies to “Merck,” making it easy to assume that Palantir’s pharmaceutical partnership connected Peter Thiel with Robert Davis. The available corporate records do not support that conclusion.
Peter Thiel and Robert Davis: What Is Actually Verified?
For this search, “Robert Davis” most plausibly refers to Robert M. Davis, chairman and chief executive officer of Merck & Co., Inc., known as MSD outside the United States and Canada.
Peter Thiel, meanwhile, is an entrepreneur and technology investor best known for PayPal, Palantir Technologies, Founders Fund and his early investment in Facebook. Palantir’s current corporate information identifies Thiel as a co-founder and says he has served as chairman of its board since 2003.
The basic comparison is straightforward:
| Person | Main current role | Major organizations | Verified direct connection to the other |
|---|---|---|---|
| Peter Thiel | Investor, Founders Fund partner and Palantir co-founder/chairman | Palantir, Founders Fund, Thiel Capital | No publicly documented direct relationship |
| Robert M. Davis | Chairman and CEO of Merck & Co., Inc. | Merck & Co.; previously Baxter and Eli Lilly | No publicly documented direct relationship |
The important indirect link involves Palantir and a different Merck company, not Davis himself.
Who Is Peter Thiel?
Peter Thiel is a German-born American entrepreneur and investor whose career spans online payments, data software and venture capital.
He co-founded PayPal and served as its chief executive before the company was acquired by eBay in 2002. He later became Facebook’s first outside investor and co-founded Palantir Technologies. He is also a partner at Founders Fund, which has invested in major technology companies across sectors including aerospace, financial technology and artificial intelligence.
Palantir remains one of the clearest parts of Thiel’s current professional profile. Palantir’s investor relations records list him on its board, while its corporate board biography states that he has served as chairman since the company’s early years.
Thiel’s wealth is also substantially tied to technology investments. Forbes estimated his real-time net worth at roughly $35 billion as of September 12, 2026, although billionaire wealth estimates can change considerably as public and private company valuations move.
Who Is Robert M. Davis?
Robert M. “Rob” Davis is the chairman and CEO of Merck & Co., Inc., the American pharmaceutical company headquartered in New Jersey.
According to Merck’s official leadership biography, Davis joined the company in 2014 as chief financial officer. His responsibilities later expanded to corporate strategy, business development, information technology and procurement. He became president in April 2021, CEO on July 1, 2021, and chairman of the board on December 1, 2022.
Before Merck, Davis worked at Baxter International, where his positions included president of the medical products business, chief financial officer and treasurer. Earlier, he spent approximately 14 years at Eli Lilly and Company. He holds a law degree and an MBA from Northwestern University as well as a bachelor’s degree in finance from Miami University.
Davis continues to lead Merck in 2026. The company reported worldwide sales of $65.0 billion for 2025 and projected 2026 sales of between $65.5 billion and $67.0 billion when it published its full-year 2025 results in February 2026.
Reliable public sources establish Davis’s executive compensation through corporate disclosures, but they do not provide an authoritative figure for his personal net worth. Estimates on biography and celebrity-finance websites therefore should not be treated as verified personal wealth.
The Merck Confusion Behind the Peter Thiel Connection
The most important fact for understanding this keyword is that two unrelated companies use the Merck name.
One is Merck & Co., Inc., the American pharmaceutical company led by Robert M. Davis.
The other is Merck KGaA, Darmstadt, Germany, a German science and technology company with roots dating to 1668.
Merck KGaA explicitly states that the two organizations are different and unaffiliated companies. Their histories separated after the German company’s U.S. business was expropriated during World War I in 1917. In the United States and Canada, the German organization now uses names including MilliporeSigma, EMD Serono and EMD Electronics.
This distinction explains much of the apparent Peter Thiel and Robert Davis connection.
The two Merck companies are not interchangeable
Using “Merck” without specifying the company can produce a misleading chain:
Peter Thiel → Palantir → Merck → Robert Davis
The problem lies in the third step.
Palantir’s well-documented technology partnership was with Merck KGaA, Darmstadt, Germany, not with Robert Davis’s Merck & Co.
Therefore, that corporate partnership does not establish a professional relationship between Thiel and Davis.
What Was Palantir’s Relationship With Merck KGaA?
There was a genuine and substantial relationship between Palantir Technologies and the German Merck organization.
Merck KGaA reported that during the first half of 2017 it entered a cooperation with Palantir to use the technology company’s advanced data analytics capabilities. The initial applications focused on cancer treatment and patient services, with broader aims including faster medicine development, commercialization and improved patient outcomes.
This was not merely an informal technology experiment.
Syntropy
In 2018, Merck KGaA and Palantir announced Syntropy, a joint venture designed to help researchers integrate and analyze biomedical information that would otherwise remain separated across different institutions and systems.
Merck KGaA’s annual report described Syntropy as a platform based on Palantir Foundry. Its purpose was to standardize and connect research information while allowing participating researchers and institutions to retain ownership of their data.
The collaboration was aimed particularly at improving the ability of cancer researchers to work with large, fragmented datasets.
Merck KGaA’s later financial reporting continued to identify Syntropy Technologies LLC as an investment accounted for under the equity method, demonstrating that the relationship went beyond a one-off announcement.
None of those records identifies Robert M. Davis as the Merck executive behind the arrangement.
Also Read: Selena Gomez and Robert Davis
Who Led the Merck Side of the Palantir Relationship?
The timing provides another useful check.
When the original Palantir cooperation was announced in 2017 and Syntropy followed in 2018, Robert M. Davis was working at the American Merck & Co., not running Germany’s Merck KGaA.
Merck KGaA’s material on the Syntropy project identifies Stefan Oschmann, then chairman of the German company’s executive board, in connection with the initiative.
Robert Davis therefore should not be substituted for the executives of Merck KGaA simply because he later became CEO of a company that uses the Merck name in the United States.
Did Peter Thiel Personally Run the Merck Collaboration?
It is also useful to separate Peter Thiel from Palantir’s day-to-day management.
Thiel co-founded Palantir and has served as chairman of its board, but Alex Karp is Palantir’s chief executive officer. Palantir’s 2025 annual filing, signed in February 2026, identifies Karp as CEO and director, Stephen Cohen as president and director, and Thiel as a director.
As a result, describing every Palantir commercial agreement as a personal Peter Thiel deal can exaggerate his individual involvement.
The Palantir-Merck KGaA relationship certainly creates an organizational link to a company Thiel helped establish. It does not, by itself, prove that Thiel personally negotiated the arrangement or maintained a direct relationship with executives from an entirely different Merck organization.
Is There Evidence of a Direct Thiel-Davis Business Relationship?
No authoritative public corporate record currently establishes a direct business relationship between Peter Thiel and Robert M. Davis.
There is no well-documented indication that:
- Davis worked for Palantir, Founders Fund or Thiel Capital.
- Thiel served on the board or executive team of Merck & Co.
- Thiel and Davis founded or managed a company together.
- One publicly disclosed a personal investment in a business controlled by the other.
- They are relatives.
- The Palantir-Merck KGaA partnership placed Davis in a management or negotiating role.
This does not make it impossible that the two executives have met at an industry event or have overlapping professional contacts. It means only that such a personal connection should not be presented as fact without reliable evidence.
Why Do Searches for Peter Thiel and Robert Davis Appear Together?
Several factors can generate a paired search even when no significant direct relationship exists.
First, both names are associated with large companies operating at the intersection of technology, data, healthcare and corporate investment.
Second, Palantir has significant healthcare and life-sciences work. That makes pharmaceutical executives and Palantir leaders appear in overlapping business topics even without personal relationships.
Most importantly, the existence of two unrelated Merck organizations makes automated summaries particularly vulnerable to mixing entities. A source saying “Palantir partnered with Merck” can easily be misunderstood as referring to Merck & Co. unless the source specifically identifies Merck KGaA, Darmstadt, Germany.
That small naming difference completely changes the relationship.
Peter Thiel and Robert Davis Have Very Different Career Paths
Their professional histories also show why treating them as established associates would be misleading.
Thiel built his reputation through entrepreneurship and investment. His major career milestones include PayPal, Facebook, Palantir, Founders Fund and other technology investments.
Davis followed a traditional senior corporate leadership path through major healthcare companies. His career includes Eli Lilly, Baxter and Merck & Co., with substantial experience in finance, operations, strategy and pharmaceutical management.
Their industries overlap increasingly because modern pharmaceutical companies depend heavily on data analytics, artificial intelligence and software. Industry overlap, however, is not the same thing as a documented personal or financial connection.
What Can Be Said With Confidence?
The reliable evidence supports three clear points.
First, Peter Thiel co-founded Palantir and remains associated with the company at board level.
Second, Robert M. Davis is chairman and CEO of Merck & Co., Inc.
Third, Palantir collaborated with Merck KGaA, Darmstadt, Germany, including through the Syntropy joint venture. Merck KGaA explicitly confirms that it and Robert Davis’s Merck & Co. are separate, unaffiliated businesses.
Those facts do not establish a direct Peter Thiel-Robert Davis relationship.
FAQ
Are Peter Thiel and Robert Davis business partners?
There is no authoritative public evidence showing Peter Thiel and Merck & Co. CEO Robert M. Davis as business partners. Their major companies and publicly documented professional histories do not show a direct partnership.
Did Peter Thiel’s Palantir work with Robert Davis’s Merck?
The widely reported Merck partnership involved Merck KGaA, Darmstadt, Germany, not Merck & Co., Inc., which Robert Davis leads. Merck KGaA confirms that the two companies are separate and unaffiliated.
What was the Palantir and Merck partnership?
Palantir and Merck KGaA initially worked together on advanced data analytics, including applications in cancer treatment and patient services. They later created Syntropy, a joint venture intended to help researchers integrate and analyze biomedical data more effectively.
Who is Robert Davis in the Peter Thiel and Robert Davis search?
In a major-company or CEO context, the name most likely refers to Robert M. “Rob” Davis, chairman and CEO of Merck & Co. Because Robert Davis is a common name, searches without an employer or middle initial can also refer to unrelated people.
Does Peter Thiel own Merck?
There is no basis for describing Peter Thiel as an owner or controlling shareholder of Merck & Co. His relevant pharmaceutical connection in this context comes through Palantir’s technology relationship with the separate German company Merck KGaA.
Are Merck & Co. and Merck KGaA the same company?
No. They are separate and unaffiliated companies. Merck KGaA states that the two businesses have been entirely separate since 1917, despite both continuing to use the Merck name in different markets.
Also Read: Susan Wojcicki and Robert Davis
